RxDoctor Payments Data

Kenneth Hughes, MD

Otolaryngology · Lexington, KYNPI 1154425411

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Stryker at 25.4% of the total.

$3,870in general payments, 2019–2025

Across 139 payments — averaging $27.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$983
  • Sanofi$907
  • Regeneron Healthcare Solutions, Inc.$610
  • GSK$251
  • Kaleo, Inc.$182
  • Inspire Medical Systems, Inc.$128
  • plus $808 from 20 others

What the payments were for

  • Food & beverage$3,72696%
  • Education$1434%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,870 in reported general payments places this provider in the 80th percentile of 137 otolaryngology providers in Kentucky.

See all otolaryngology providers in Kentucky

Medicare billing

Part B allowed, 2024
$93,905
Medicare patients
461
Services billed
1,259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab39$147,289
Ipratropium Bromide66$1,967
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,119
Azelastine Hcl44$884
Ofloxacin19$848
Tobramycin-DexamethasoneTobramycin/Dexamethasone16$830
Prednisolone Acetate16$758
Esomeprazole Magnesium29$535
Famotidine74$435
Ondansetron OdtOndansetron36$361
Montelukast Sodium50$332
Cefdinir19$331
Fluticasone Propionate29$307
Levocetirizine Dihydrochloride31$260
Betamethasone Valerate13$223

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →